This metabolite includes a PDE selectivity profile much like sildenafil and an in vitro potency for PDE5 about 50% from the father or mother drug. Plasma concentrations of this metabolite are approximately forty% of These seen for sildenafil, so that the metabolite accounts for approximately twenty% of sildenafil's pharmacologic results.In the even